Now that Onyx has been consumed, let's look at the next round of acquisition suspects in biotech. Fierce Biotech provided a good recap yesterday morning. Without further adieu, we have the following companies in the cross hairs according to Fierce:
- Seattle Genetics
Now you can mull that over for your next round of investment speculation.
Posted by Bruce Lehr Aug 29th 2013.